iSpecimen Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.9M | $9.3M | $9.9M | $10.4M | $11.1M |
| Operating income | -$9.0M | -$12.7M | -$11.2M | -$10.2M | -$5.9M |
| Cost of revenue | $1.9M | $5.3M | $4.8M | $4.8M | $5.2M |
| Cash from operations | -$4.2M | -$8.3M | -$5.8M | -$5.8M | -$10.7M |
| Capital expenditure | $454 | $31,546 | $19,478 | $215,504 | $2,550 |
| Free cash flow | -$4.2M | -$8.3M | -$5.8M | -$6.0M | -$10.7M |
| Impairments | — | — | — | — | $0 |
| Total assets | $9.5M | $9.4M | $15.8M | $24.6M | $35.7M |
| Total liabilities | $6.4M | $6.0M | $6.1M | $4.3M | $5.9M |
| Total debt | — | — | — | — | $3.5M |
Shares outstanding 1.4M
Annual filing data through FY ended December 31, 2025; float as of July 2, 2026.